Alexandria, VA. USA

Course Dates: TBD

GET TICKETSSEE PROGRAM

Valencia-Madrid, SPAIN 

Course Dates: TBD

GET TICKETSSEE PROGRAM

Riyadh, Saudi Arabia

Course Dates: TBD

GET TICKETSSEE PROGRAM

Cruise > BAHAMAS

Course Dates: TBD

GET TICKETSSEE PROGRAM

Why Attend Our Course

Earn 20 AMA PRA Category 1 Credits

Our course is a training-based forum for professionals committed to Precision Medicine methods in routine healthcare delivery.  Participants on completion earn 20 AMA PRA Category 1 Credits™ from our CME-accredited partner George Washington University School of Medicine.

Conference Breakdown

3 to 5 days and 20 hours of a CME-accredited, course-structured training that is focused on Precision Medicine applied learning, global adoption, and effective commercialization; 5 core themes and over 15 panels or tracks, including showcases, case studies, workshops, presentations.

Global Mandate

Courses are designed as learning platforms for Precision Medicine stakeholders worldwide who share in common the same professional mandate or corporate mission: To apply next-generation Precision Medicine standards into routine healthcare delivery.

Network Globally, Locally

Exchange information with peers from across the world, from diverse academic, scientific, and commercial sectors, who like you share one common purpose: Learn and commercialize next generation Precision Medicine methods for enhancing patient diagnosis and therapy.

Meet The Disruptors

Leaders from corporate, non-profit, and governmental arenas deliver latest developments in technologies, digital health, business models, delivery channels, and regulations most likely to disrupt the adoption and scaling of Precision Medicine.

Economic & Business Models

You’ll learn first-hand about evolving economic models of Precision Medicine that are enabling sustainable and scalable businesses which, at the same time, are changing how diseases are being diagnosed and patients treated.

Venues

Our unique training-based learning forums take place in global destinations across the Americas, Europe, Far East, and the Middle East known for advancing the science, technology, and delivery infrastructures for Precision Medicine.

Program Description

Deliver differentiated awareness and knowledge of the key challenges affecting the adoption, implementation, and commercialization of Precision Medicine as an effective model of healthcare.

Equip medical & health sciences practitioners with unique Precision Medicine tools and training with tremendous potential to improving their patient diagnoses, outcomes, and monitoring.

Support Precision Medicine stakeholders with academic, scientific, and commercial partnerships aimed at demonstrating Precision Medicine best practices on a global scale.

Offer healthcare professionals our unique learning platform, focused on Precision Medicine implementation and commercialization, that is AMA-certified as Continuing Medical Education.

Clinical use and interpretation of LDTs for enhanced diagnosis and therapy of patients.

Laboratory and information technologies and their regulatory environments in healthcare.

Precision Medicine business models, marketing, commercialization and reimbursement.

Ethical, legal, economic, social and operational issues: molecular biomarkers, genomic data, aggregated clinical data, and patient reported data are being brought to predict disease susceptibility, refine diagnoses, and personalize treatments.

Background and New Trends in Precision Medicine

Precision Medicine Adoption, Regulation and Outcomes Monitoring

Economics and Business Models of Precision Medicine

Clinical Case Studies in Precision Internal Medicine

Clinical Case Studies in Precision Cancer Medicine

  • Concepts and methods of Molecular Medicine.
  • Signature genes and molecules to each patient’s mechanism of disease and response to environmental factors, food and drugs.
  • Translating genomic data into clinical practice for healthcare improvement.
  • Complementary and companion diagnostic tests tailoring diagnosis and therapy to each patient.
  • Precision Medicine delivery models cost effectiveness and metrics.
  • Human resources, technologies, and infrastructures of Precision Medicine.
  • IT and digital health impacts on Precision Medicine outcomes.
  • Artificial intelligence, interactive simulation and point of care technologies in Precision Medicine.
  • Companies developing clinical technologies and providing clinical services in recision Medicine.
  • Marketing and commercialization models; reimbursement/non-reimbursement markets.
  • The economic models of Precision Medicine, including sustainable and scalable business.
  • Blockchain technologies in the logistical management of Precision Medicine data.
  • Clinical cases on immune-inflammatory, endocrine-metabolic, and neurodegenerative disorders.
  • LDTs identifying changes that occur at key pathogenic pathways of the patients will help to tailor diagnosis and therapy to each patient’s disease using molecular and genetic data.
  • Most prevalent malignancies in lung, colorectal, breast, prostate and skin will be used to show how molecular biomarkers and genomic data from the tumor and the tumor microenvironment are associated with aggregated pathophysiological data to refine diagnosis and personalize therapy.

Our Courses are designed for health sciences stakeholders with demonstrated interest in and need for 1) understanding concepts and methods of Precision Medicine, and 2) integrating molecular & genetic guidance, and newest medical bioengineering solutions & big-data analytics into routine healthcare delivery.  Participants will earn 20 AMA PRA Category 1 Credits™ on completion.

The information provided in this Course is for medical education and nformational purposes only. It should not be construed as personal medical advice and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition. The opinions expressed in this educational course are those of the faculty and do not necessarily represent the views of organizers of the Course. For any question or concern about a medical matter, participants at the course should refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Course Director & Main Speaker

Scientist, Physician, Academician, Innovator, Entrepreneur

Fernando Vidal-Vanaclocha

Persona Biomed Chief Science Officer Fernando Vidal-Vanaclocha, MD, PhD, is a physician scientist, trained in Pathology, and a professor of Translational Molecular Medicine. Mr. Vidal-Vanaclocha has extensive experience in discovery and translational research in Oncology, Inflammation and Regenerative Medicine.

Among his scientific and academic peer group, he has distinguished himself by having successfully commercialized and moved to market laboratory discoveries and applications.  He’s launched and sold several biotech entities in Spain (INBIOMED, PHARMAKINE, IMMA) and in the USA (BIOPHARMANCE) that develop and take to market products and services for molecular diagnosis and target-oriented therapeutics. 

Mr. Vidal-Vanaclocha is adjunct professor at the George Washington University School of Medicine and Health Sciences in Washington, D.C.

CONTACT US

PHONE NUMBER

+1 703-299-0246

EMAIL ADDRESS

dc@personabiomed.com

Headquarters USA

625 N Washington St #425, Alexandria, VA 22314, USA

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!